![]() | Up a level |
van der Wall, Sake J, Teutsch, Christine, Dubner, Sergio J, Diener, Hans-Christoph, Halperin, Jonathan L, Ma, Chang Sheng, Rothman, Kenneth J, Paquette, Miney, Zint, Kristina, França, Lionel Riou et al (show 4 more authors)
(2021)
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.
TH open : companion journal to thrombosis and haemostasis, 5 (1).
e35-e42.
Dubner, Sergio J, Teutsch, Christine, Huisman, Menno V, Diener, Hans-Christoph, Halperin, Jonathan, Rothman, Kenneth J, Ma, Chang-Sheng, Chuquiure-Valenzuela, Eduardo, Bergler-Klein, Jutta, Zint, Kristina et al (show 4 more authors)
(2020)
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.
ESC HEART FAILURE, 7 (5).
pp. 2679-2689.
Paquette, Miney, Franca, Lionel Riou, Teutsch, Christine, Diener, Hans-Christoph, Lu, Shihai, Dubner, Sergio J, Ma, Chang Sheng, Rothman, Kenneth J, Zint, Kristina, Halperin, Jonathan L et al (show 4 more authors)
(2020)
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
AMERICAN JOURNAL OF CARDIOLOGY, 125 (3).
pp. 383-391.
Koziel, Monika, Mazurek, Michal, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Brandes, Axel, Paquette, Miney et al (show 6 more authors)
(2020)
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
JOURNAL OF CLINICAL MEDICINE, 9 (6).
E1969-.
Mazurek, Michał, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Paquette, Miney, Zint, Kristina, França, Lionel Riou et al (show 5 more authors)
(2019)
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
American heart journal, 218.
pp. 123-127.